PATENT CLAIM ANALYSIS

Application Number: 15879052
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure provides compositions and methods for improving the efficacy of enzyme replacement therapy for lysosomal storage diseases.

Claim (Index 19):
The method according to  claim 18 , wherein the therapeutic candidate is chemically conjugated to one or more N-acetylgalactosamine (GalNAc) molecules or encapsulated in a delivery vehicle.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.05263
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13391265', '13253005', '12801404', '14936568', '15438375']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7632631035556441
- 35 USC 102 Novelty (BERT): 0.5286088447265196
- Combined Prediction Score: 0.7397976776727316
- Mean Citation Score: 234.578618
- Max Citation Score: 247.39505
- Similarity Product: 110.01755262462498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test